UTAH MED PRODS INC's ticker is UTMD and the CUSIP is 917488108. A total of 77 filers reported holding UTAH MED PRODS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $61,534 | +2.3% | 716 | +10.8% | 0.00% | – |
| Q2 2023 | $60,161 | +20.3% | 646 | +22.3% | 0.00% | – |
| Q1 2023 | $49,991 | +163.1% | 528 | +182.4% | 0.00% | – |
| Q4 2022 | $19,000 | +18.8% | 187 | 0.0% | 0.00% | – |
| Q3 2022 | $16,000 | -11.1% | 187 | -7.4% | 0.00% | – |
| Q2 2022 | $18,000 | 0.0% | 202 | 0.0% | 0.00% | – |
| Q1 2022 | $18,000 | -18.2% | 202 | -4.7% | 0.00% | – |
| Q4 2021 | $22,000 | +4.8% | 212 | -4.9% | 0.00% | – |
| Q3 2021 | $21,000 | +10.5% | 223 | 0.0% | 0.00% | – |
| Q2 2021 | $19,000 | 0.0% | 223 | +0.5% | 0.00% | – |
| Q1 2021 | $19,000 | +137.5% | 222 | +128.9% | 0.00% | – |
| Q4 2020 | $8,000 | -68.0% | 97 | -67.6% | 0.00% | – |
| Q3 2020 | $25,000 | -7.4% | 299 | 0.0% | 0.00% | – |
| Q2 2020 | $27,000 | -18.2% | 299 | -16.7% | 0.00% | – |
| Q1 2020 | $33,000 | – | 359 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Clean Yield Group | 49,094 | $3,535,000 | 1.48% |
| MORGAN DEMPSEY CAPITAL MANAGEMENT LLC | 27,464 | $1,988,000 | 0.72% |
| Ativo Capital Management LLC | 16,525 | $1,196,000 | 0.33% |
| Ancora Advisors LLC | 55,159 | $3,993,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 10,754 | $779,000 | 0.23% |
| Cardinal Capital Management | 9,180 | $665,000 | 0.22% |
| Acrospire Investment Management LLC | 1,919 | $139,000 | 0.13% |
| Penobscot Investment Management Company, Inc. | 4,000 | $290,000 | 0.09% |
| TFS CAPITAL LLC | 3,226 | $234,000 | 0.09% |
| WCM INVESTMENT MANAGEMENT, LLC | 81,912 | $5,930,000 | 0.09% |